Pyridoxamine does not reduce arterial stiffness in an 8-week randomized double-blind placebo-controlled intervention trial with abdominally obese individuals

Mathias D. G. Van den Eynde, Myrthe M. van der Bruggen, Alfons J. H. M. Houben, Koen D. Reesink, Bart Spronck, Tammo Delhaas, Jean J. L. J. M. Scheijen, Toshio Miyata, Casper G. Schalkwijk*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)5332-5336
Number of pages5
JournalDiabetes, Obesity and Metabolism
Volume27
Issue number9
DOIs
Publication statusPublished - Sept 2025

Bibliographical note

Copyright the Author(s) 2025. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Keywords

  • abdominal obesity
  • advanced glycation end products
  • arterial stiffness
  • dicarbonyl stress
  • pyridoxamine

Cite this